Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients

Gunnar Wichmann(Leipzig University of Applied Sciences), Veit Zebralla(University Hospital Leipzig), Regine Kluge(Klinik und Poliklinik für Nuklearmedizin), Florian Lordick(Leipzig University), Thomas Kuhnt(Leipzig University), Tanja Gradistanac(Leipzig University), Susanne Wiegand, Andreas Dietz(Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde), Theresa Wald(University Hospital Leipzig), Sandra Fest(University Hospital Leipzig), Maria Willner(University Hospital Leipzig)
Frontiers in Oncology
May 7, 2021
10.3389/fonc.2021.682088
Cited by 7

Related Papers

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
|The Lancet|2010|7.3k
Gastric cancer
|The Lancet|2020|4.8k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer
|Journal of Clinical Oncology|2020|1.2k